MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$664,328K
Cash and cash
equivalents
$115,077K
Accounts receivable, net
$53,383K
Inventory
$13,266K
Short-term portion of
financial royalty assets,...
$12,151K
Other current assets
$5,795K
Income taxes
receivable
$1,415K
Total current assets
$865,415K
Intangible assets, net
$217,341K
Long-term portion of
financial royalty assets,...
$193,536K
Goodwill
$101,541K
Other investments
$87,770K
Equity method
investments
$31,515K
Noncurrent derivative
assets
$13,527K
Other assets
$12,987K
Deferred income taxes,
net
$8,473K
Total assets
$1,532,105K
Total liabilities and
stockholders equity
$1,532,105K
Total stockholders
equity
$997,322K
Total liabilities
$534,783K
Retained earnings
$594,743K
Additional paid-in capital
$397,169K
Accumulated other
comprehensive income
$5,390K
Common stock, 0.001 par
value 60,000 shares...
$20K
2030 convertible
senior notes, net
$446,896K
Total current
liabilities
$40,667K
Deferred income taxes,
net
$22,614K
Other long-term
liabilities
$17,115K
Long-term operating lease
liabilities
$3,993K
Long-term contingent
liabilities
$3,498K
Accrued liabilities
$31,845K
Accounts payable
$5,264K
Income taxes payable
$1,893K
Current operating lease
liabilities
$1,088K
Other current
liabilities
$300K
Current contingent
liabilities
$277K
Back
Back
Balance Sheet
LIGAND PHARMACEUTICALS INC (LGNDZ)
LIGAND PHARMACEUTICALS INC (LGNDZ)
source: myfinsight.com